COVID-19 and diabetes: The contributions of hyperglycemia

26Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Coronavirus disease 2019 (COVID-19) caused by coronavirus SARS-CoV-2 infection has now evolved into a worldwide crisis that triggers substantial morbidity and mortality. COVID-19 occurs more frequently and has more serious complications in patients with diabetes mellitus, but the underlying mechanisms remain largely elusive. Here, we summarize current and evolving concepts on the detrimental effect of hyperglycemia on SARSCoV-2 infection and consequences, focusing on several key mechanisms underlying the link between diabetes and COVID- 19. A better understanding of the mechanisms by which hyperglycemia worsens the prognosis of COVID-19 is critical for reducing the risk of SARS-CoV-2 infection and its associated mortality.

Cite

CITATION STYLE

APA

Wang, J., & Meng, W. (2020). COVID-19 and diabetes: The contributions of hyperglycemia. Journal of Molecular Cell Biology, 12(12), 958–962. https://doi.org/10.1093/jmcb/mjaa054

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free